Abhilasha Khanna & Samudra Sarangi
Latest
NPPA & Overcharging: The MRP v. ASP conundrum
Until not that along ago, drugs and medical devices were distinct from each other and it was this distinction that kept manufacturers of medical devices away the clutches of India's pricing regulator
More Authors You Might Like
-
Kristopher Tait
US Managing Director, Croud
-
Mike Chisholm
President & CEO of A & A Customs Brokers
-
Alex Quin
CMO and Founder
-
Carl Stoffers
Senior Business Editor
-
Nikola Baldikov
CEO at InBound Blogging
-
Sherin Shibu
News Reporter
-
Amanda Breen
Senior Features Writer
-
David James
Staff writer